Skip to main content

Analyst doubles Apple Watch sales prediction to 12 million sold in 2015

corning gorilla glass sr apple watch sport  350
Image used with permission by copyright holder
Although it may have had a rough start, Apple Watch sales are finally picking up some steam, according to analysts.

With Best Buy and Target offering discounts on the the Watch during the Thanksgiving weekend, FBR & Co. analyst Daniel Ives predicts that sales could reach 6 million for the three-month period leading up to the end of 2015, doubling his estimated total sales figure for the year to 12 million, according to Apple Insider.

Recommended Videos

In early November, Canalys reported that the smartwatch reached 7 million sales, lower than what analysts predicted for Apple’s first wearable. Morgan Stanley analyst Katy Huberty said the Apple Watch would reach 30 million sales in the first year, but KGI Securities analyst Ming Chi-Kuo predicted 15 million sales, a much closer estimate to Ives’ claim of 12 million.

Please enable Javascript to view this content

Ives used anecdotal evidence and checked with Apple retail stores on Friday to reach his conclusions. In his note to investors, he said that the wearable devices market will be a $20-billion-plus market opportunity for Apple.

“We continue to view the Apple Watch as a potential door opener for wearable technology across the board, as this next paradigm shift is likely set to take place across the consumer/enterprise landscape,” he wrote.

IBM’s Watson Trend report also mentioned that the Apple Watch is at the top of consumer shopping lists.

Apple, as usual, is keeping quiet on sales numbers, but the company did say in July that the Apple Watch outsold the first-generation iPad in its first nine weeks in the market.

Also related: Apple Watch review (Updated for OS 2.0)

While Apple Watch sales may not have met initial expectations, the company is far from losing its place in the wearable market. In fact, Strategy Analytics reported that Apple took the largest share of wearable sales during the July-September period, a whopping 72.8 percent. The market share doesn’t look too good for Samsung, as it dropped to 9.8 percent.

Julian Chokkattu
Former Digital Trends Contributor
Julian is the mobile and wearables editor at Digital Trends, covering smartphones, fitness trackers, smartwatches, and more…
The Apple Watch Series 10 has ruined smartwatches for me
A person wearing the aluminum Apple Watch Series 10.

That’s it, the Apple Watch Series 10 has ruined other smartwatches for me. This week I will swap to another smartwatch I have to review, but I don’t want to take the Apple Watch off. It's wonderful.

I don’t want to use the word perfect because, of course, it’s not, but it’s very, very close to it. Prepare for some gushing over the next few hundred words, as I’m going to explain why if you’re looking for a smartwatch, the search can stop with the Apple Watch Series 10.
Why don’t I want to take it off?

Read more
I already damaged my Apple Watch Series 10
i already damaged my apple watch series 10 dt 1

I don’t think I’m clumsy, but I swing my arms a lot and still grimace every time a smartwatch on my wrist hits an immovable object. Yet, for all this movement, I’ve never managed to deeply scratch or lightly crack an Apple Watch display … until now.

The Apple Watch Series 10 doesn’t have many compromises over the Apple Watch Ultra 2, and I even made the switch permanently before this happened. It’s big, thin, and beautiful, but the Apple Watch Series 10 also uses a less durable protective shield for its display.

Read more
Blood oxygen tracking isn’t coming back to the Apple Watch anytime soon
Apple Watch Ultra taking a measurement for blood oxygen levels.

One of the major selling points of Apple Watches in recent years has been the ability to test users’ blood oxygen levels. Unfortunately, ongoing litigation has prevented this feature from being included in Apple Watches sold in the U.S. since January. Now, it seems unlikely that this situation will change soon.

On Friday, a Delaware jury found that health-monitoring technology company Masimo infringed on some of Apple’s earlier smartwatch patents. As a result, Apple received an award of only $250. However, the same jury ruled that Masimo's current watches did not infringe on the patents that Apple accused it of copying. Consequently, an injunction remains in effect in the U.S. that prevents the company from offering blood oxygen tracking on new watches sold in the country.

Read more